• Home
  • Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.

Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.

Author List
Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS
Publication
The Prostate
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1450954
Publication Year
2007
PubMed ID
17044080
Publication Title
Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history. Prostate. 2007 Feb 01; 67(2):172-7.